JBR Co Financial Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
4,629
-425
-8% -$91.4K 0.43% 52
2026
Q1
$1.15M Hold
5,054
0.48% 49
2025
Q4
$1.15M Sell
5,054
-114
-2% -$26K 0.48% 49
2025
Q3
$1.2M Sell
5,168
-3
-0.1% -$611 0.51% 46
2025
Q2
$960K Sell
5,171
-127
-2% -$23.6K 0.47% 50
2025
Q1
$1.11M Hold
5,298
0.65% 43
2024
Q4
$941K Sell
5,298
-1,140
-18% -$210K 0.57% 43
2024
Q3
$1.27M Hold
6,438
0.83% 30
2024
Q2
$1.1M Sell
6,438
-135
-2% -$22.4K 0.78% 35
2024
Q1
$1.2M Sell
6,573
-52
-0.8% -$8.96K 0.96% 29
2023
Q4
$1.03M Buy
+6,625
New +$966K 0.96% 29

Other funds holding ABBV

JBR Co Financial Management's ABBV Position: Q2 2026 in Review

JBR Co Financial Management reduced its AbbVie (ABBV) stake by 8.4% in Q2 2026, selling an estimated $91.4K and leaving 4,629 shares worth $1.16M. The position accounts for 0.43% of the portfolio, ranked #52.

JBR Co Financial Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.27M in Q3 2024. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • JBR Co Financial Management held 4,629 shares of AbbVie worth $1.16M as of Q2 2026.
  • JBR Co Financial Management sold 425 AbbVie shares in Q2 2026, an estimated $91.4K.
  • AbbVie made up 0.43% of JBR Co Financial Management's portfolio in Q2 2026, its #52 holding.
  • JBR Co Financial Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • JBR Co Financial Management's AbbVie position peaked at $1.27M in Q3 2024.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on JBR Co Financial Management's 13F filing for Q2 2026, filed 9 Jul 2026.